These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6368855)

  • 21. Antibiotics for penetrating abdominal trauma: a prospective comparative trial of single agent cephalosporin therapy versus combination therapy.
    Bivins BA; Crots L; Obeid FN; Sorensen VJ; Horst HM; Fath JJ
    Diagn Microbiol Infect Dis; 1989; 12(1):113-8. PubMed ID: 2714067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial management of surgically treated gangrenous or perforated appendicitis: comparison of cefoxitin and clindamycin-gentamicin.
    Sirinek KR; Levine BA
    Clin Ther; 1987; 9(4):420-8. PubMed ID: 3607822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections.
    Drusano GL; Warren JW; Saah AJ; Caplan ES; Tenney JH; Hansen S; Granados J; Standiford HC; Miller EH
    Surg Gynecol Obstet; 1982 May; 154(5):715-20. PubMed ID: 7041297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefoxitin versus clindamycin and gentamicin in the treatment of postcesarean section infections.
    Herman G; Cohen AW; Talbot GH; Coghlan R; Faidley-Mangen P; MacGregor RR
    Obstet Gynecol; 1986 Mar; 67(3):371-6. PubMed ID: 3511419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomized study of moxalactam versus gentamicin and clindamycin in penetrating abdominal trauma.
    Kreis DJ; Augenstein D; Martinez O; Echenique M; Plasencia G; Vopal JJ; Byers P; Gomez GA
    Surg Gynecol Obstet; 1986 Jul; 163(1):1-4. PubMed ID: 3726718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days.
    Kirton OC; O'Neill PA; Kestner M; Tortella BJ
    J Trauma; 2000 Nov; 49(5):822-32. PubMed ID: 11086771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefmetazole versus cefoxitin in prevention of infections after abdominal surgery.
    Plouffe JF
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():85-8. PubMed ID: 2722727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections.
    Larsen JW; Voise CT; Grossman JH
    Clin Ther; 1986; 9(1):77-83. PubMed ID: 3815461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative intraparietal (intra-incisional) cefoxitin in abdominal surgery.
    Taylor TV; Walker WS; Mason RC; Richmond J; Lee D
    Br J Surg; 1982 Aug; 69(8):461-2. PubMed ID: 7049308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of a double-blind, placebo-controlled clinical trial program of single-dose ceftizoxime versus multiple-dose cefoxitin as prophylaxis for patients undergoing vaginal and abdominal hysterectomy.
    McGregor JA; Phillips LE; Roy S; Dunne JT; Warwaruk AS; Johnston DW; Yuzpe AA; Hemsell DL
    J Am Coll Surg; 1994 Feb; 178(2):123-31. PubMed ID: 8173721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic antibiotics in patients undergoing total vaginal or abdominal hysterectomy.
    Tchabo JG; Cutting ME; Butler C
    Int Surg; 1985; 70(4):349-52. PubMed ID: 3914473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus.
    Feliciano DV; Gentry LO; Bitondo CG; Burch JM; Mattox KL; Cruse PA; Jordan GL
    Am J Surg; 1986 Dec; 152(6):674-81. PubMed ID: 3789294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized prospective study of antibiotic prophylaxis during abdominal surgery.
    Gaskill HV; Levine BA
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():79-83. PubMed ID: 2722726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic prophylaxis in appendiceal surgery. A prospective and comparative study of cefoxitin and a combination of clindamycin and gentamycin].
    Armengol M; Oller B; Fernández-Llamazares J; Piñol M; Camps I; Broggi MA; Salvá JA
    Rev Quir Esp; 1988; 15(2):76-8. PubMed ID: 3153369
    [No Abstract]   [Full Text] [Related]  

  • 35. Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma.
    Crots LD; Obeid FN; Horst HM; Bivins BA
    Clin Pharm; 1985; 4(3):316-20. PubMed ID: 3891203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy.
    Malangoni MA; Condon RE; Spiegel CA
    Surgery; 1985 Oct; 98(4):648-55. PubMed ID: 3901372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective alterations in therapy for penetrating abdominal trauma.
    Nichols RL; Smith JW; Robertson GD; Muzik AC; Pearce P; Ozmen V; McSwain NE; Flint LM
    Arch Surg; 1993 Jan; 128(1):55-63; discussion 63-4. PubMed ID: 8418781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-course antibiotic prophylaxis in penetrating abdominal injuries: ceftriaxone versus cefoxitin.
    Demetriades D; Lakhoo M; Pezikis A; Charalambides D; Pantanowitz D; Sofianos C
    Injury; 1991 Jan; 22(1):20-4. PubMed ID: 2030024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-antibiotic use for penetrating abdominal trauma.
    Nelson RM; Benitez PR; Newell MA; Wilson RF
    Arch Surg; 1986 Feb; 121(2):153-6. PubMed ID: 3947216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations. Importance of the duration of the surgical procedure.
    Kaiser AB; Herrington JL; Jacobs JK; Mulherin JL; Roach AC; Sawyers JL
    Ann Surg; 1983 Oct; 198(4):525-30. PubMed ID: 6354113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.